MYCELX Technologies (MYX) Competitors

MYCELX Technologies logo
GBX 45 -1.00 (-2.17%)
As of 11/19/2026 03:13 AM Eastern

MYX vs. GRA, WYG, INCE, SNX, and BILB

Should you buy MYCELX Technologies stock or one of its competitors? MYCELX Technologies's main competitors and comparable companies include Grafenia (GRA), WYG (WYG), The Ince Group (INCE), Synectics (SNX), and Bilby (BILB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "commercial services & supplies" industry.

How does MYCELX Technologies compare to Grafenia?

MYCELX Technologies (LON:MYX) and Grafenia (LON:GRA) are both small-cap industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

18.1% of MYCELX Technologies shares are owned by institutional investors. Comparatively, 43.6% of Grafenia shares are owned by institutional investors. 30.4% of MYCELX Technologies shares are owned by insiders. Comparatively, 44.9% of Grafenia shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

MYCELX Technologies has a net margin of 6.69% compared to Grafenia's net margin of -11.78%. MYCELX Technologies' return on equity of 16.44% beat Grafenia's return on equity.

Company Net Margins Return on Equity Return on Assets
MYCELX Technologies6.69% 16.44% -24.82%
Grafenia -11.78%-82.44%-4.07%

In the previous week, MYCELX Technologies' average media sentiment score of 0.00 equaled Grafenia'saverage media sentiment score.

Company Overall Sentiment
MYCELX Technologies Neutral
Grafenia Neutral

MYCELX Technologies has a beta of 1.255, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Grafenia has a beta of 0.33, meaning that its stock price is 67% less volatile than the broader market.

Grafenia has lower revenue, but higher earnings than MYCELX Technologies. Grafenia is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MYCELX Technologies£12.18M0.90-£4.52M£3.0015.00
Grafenia£11.68M0.00-£1.41M-£0.01N/A

Summary

MYCELX Technologies beats Grafenia on 6 of the 10 factors compared between the two stocks.

How does MYCELX Technologies compare to WYG?

WYG (LON:WYG) and MYCELX Technologies (LON:MYX) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

MYCELX Technologies has a net margin of 6.69% compared to WYG's net margin of 0.00%. MYCELX Technologies' return on equity of 16.44% beat WYG's return on equity.

Company Net Margins Return on Equity Return on Assets
WYGN/A N/A N/A
MYCELX Technologies 6.69%16.44%-24.82%

In the previous week, WYG's average media sentiment score of 0.00 equaled MYCELX Technologies'average media sentiment score.

Company Overall Sentiment
WYG Neutral
MYCELX Technologies Neutral

18.1% of MYCELX Technologies shares are owned by institutional investors. 30.4% of MYCELX Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

WYG has higher revenue and earnings than MYCELX Technologies. WYG is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WYG£154.43M0.00N/A-£6.70N/A
MYCELX Technologies£12.18M0.90-£4.52M£3.0015.00

Summary

MYCELX Technologies beats WYG on 6 of the 8 factors compared between the two stocks.

How does MYCELX Technologies compare to The Ince Group?

The Ince Group (LON:INCE) and MYCELX Technologies (LON:MYX) are both small-cap industrials companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

The Ince Group has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market. Comparatively, MYCELX Technologies has a beta of 1.255, suggesting that its stock price is 26% more volatile than the broader market.

MYCELX Technologies has a net margin of 6.69% compared to The Ince Group's net margin of 0.60%. MYCELX Technologies' return on equity of 16.44% beat The Ince Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Ince Group0.60% 3.28% 3.94%
MYCELX Technologies 6.69%16.44%-24.82%

In the previous week, The Ince Group's average media sentiment score of 0.00 equaled MYCELX Technologies'average media sentiment score.

Company Overall Sentiment
The Ince Group Neutral
MYCELX Technologies Neutral

15.3% of The Ince Group shares are owned by institutional investors. Comparatively, 18.1% of MYCELX Technologies shares are owned by institutional investors. 9.9% of The Ince Group shares are owned by company insiders. Comparatively, 30.4% of MYCELX Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

The Ince Group has higher revenue and earnings than MYCELX Technologies. The Ince Group is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Ince Group£102.47M0.36£1.37M£0.8711.59
MYCELX Technologies£12.18M0.90-£4.52M£3.0015.00

Summary

MYCELX Technologies beats The Ince Group on 7 of the 11 factors compared between the two stocks.

How does MYCELX Technologies compare to Synectics?

MYCELX Technologies (LON:MYX) and Synectics (LON:SNX) are both small-cap industrials companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Synectics has higher revenue and earnings than MYCELX Technologies. MYCELX Technologies is trading at a lower price-to-earnings ratio than Synectics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MYCELX Technologies£12.18M0.90-£4.52M£3.0015.00
Synectics£54.85M0.61£2.93M£4.4044.77

18.1% of MYCELX Technologies shares are owned by institutional investors. Comparatively, 9.4% of Synectics shares are owned by institutional investors. 30.4% of MYCELX Technologies shares are owned by company insiders. Comparatively, 22.8% of Synectics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

MYCELX Technologies has a beta of 1.255, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Synectics has a beta of 0.656, suggesting that its stock price is 34% less volatile than the broader market.

In the previous week, Synectics had 4 more articles in the media than MYCELX Technologies. MarketBeat recorded 4 mentions for Synectics and 0 mentions for MYCELX Technologies. Synectics' average media sentiment score of 0.75 beat MYCELX Technologies' score of 0.00 indicating that Synectics is being referred to more favorably in the news media.

Company Overall Sentiment
MYCELX Technologies Neutral
Synectics Positive

MYCELX Technologies has a net margin of 6.69% compared to Synectics' net margin of 1.29%. MYCELX Technologies' return on equity of 16.44% beat Synectics' return on equity.

Company Net Margins Return on Equity Return on Assets
MYCELX Technologies6.69% 16.44% -24.82%
Synectics 1.29%1.64%5.02%

Summary

Synectics beats MYCELX Technologies on 7 of the 13 factors compared between the two stocks.

How does MYCELX Technologies compare to Bilby?

MYCELX Technologies (LON:MYX) and Bilby (LON:BILB) are both small-cap industrials companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

In the previous week, MYCELX Technologies' average media sentiment score of 0.00 equaled Bilby'saverage media sentiment score.

Company Overall Sentiment
MYCELX Technologies Neutral
Bilby Neutral

MYCELX Technologies has a net margin of 6.69% compared to Bilby's net margin of 0.00%. MYCELX Technologies' return on equity of 16.44% beat Bilby's return on equity.

Company Net Margins Return on Equity Return on Assets
MYCELX Technologies6.69% 16.44% -24.82%
Bilby N/A N/A N/A

Bilby has higher revenue and earnings than MYCELX Technologies. Bilby is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MYCELX Technologies£12.18M0.90-£4.52M£3.0015.00
Bilby£59.05M0.00N/A£1.20N/A

18.1% of MYCELX Technologies shares are held by institutional investors. 30.4% of MYCELX Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

MYCELX Technologies beats Bilby on 5 of the 8 factors compared between the two stocks.

Get MYCELX Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for MYX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MYX vs. The Competition

MetricMYCELX TechnologiesCommercial Services & Supplies IndustryIndustrials SectorLON Exchange
Market Cap£10.96M£4.54B£9.85B£2.70B
Dividend YieldN/A3.79%2.95%5.11%
P/E Ratio15.0038.4630.6122.88
Price / Sales0.902.892.905.01
Price / Cash1.9621.4519.7220.23
Price / Book1.764.333.632.42
Net Income-£4.52M£149.57M£612.75M£5.88B
7 Day Performance-0.22%-2.39%-3.88%-2.80%
1 Month Performance-2.17%-2.11%-4.33%-4.27%
1 Year Performance71.59%1.35%1.44%5.16%

MYCELX Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MYX
MYCELX Technologies
N/AGBX 45
-2.2%
N/A+57.9%£10.96M£12.18M15.0018
GRA
Grafenia
N/AN/AN/AN/A£41.93M£11.68MN/A92
WYG
WYG
N/AN/AN/AN/A£39.97M£154.43MN/A1,612
INCE
The Ince Group
N/AGBX 10.08
-0.9%
N/AN/A£36.99M£102.47M11.59700
SNX
Synectics
N/AGBX 193.73
-0.7%
N/A-29.2%£32.95M£54.85M44.0323,500

Related Companies and Tools


This page (LON:MYX) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners